Ameriprise’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,900
| Closed | -$79.6K | – | 4044 |
|
|
2024
Q2 | $79.6K | Sell |
34,900
-600
| -2% | -$2.29K | ﹤0.01% | 3791 |
|
|
2024
Q1 | $153K | Hold |
35,500
| – | – | ﹤0.01% | 3724 |
|
|
2023
Q4 | $108K | Sell |
35,500
-2,550
| -7% | -$4.79K | ﹤0.01% | 3806 |
|
|
2023
Q3 | $54.8K | Sell |
38,050
-89,334
| -70% | -$173K | ﹤0.01% | 3833 |
|
|
2023
Q2 | $317K | Sell |
127,384
-22,421
| -15% | -$61.3K | ﹤0.01% | 3594 |
|
|
2023
Q1 | $401K | Buy |
149,805
+33,395
| +29% | +$160K | ﹤0.01% | 3505 |
|
|
2022
Q4 | $632K | Sell |
116,410
-1,179
| -1% | -$9.88K | ﹤0.01% | 3315 |
|
|
2022
Q3 | $1.47M | Buy |
117,589
+4,866
| +4% | +$55.6K | ﹤0.01% | 2929 |
|
|
2022
Q2 | $557K | Buy |
112,723
+4,422
| +4% | +$24.5K | ﹤0.01% | 3360 |
|
|
2022
Q1 | $823K | Buy |
108,301
+7,850
| +8% | +$74.4K | ﹤0.01% | 3290 |
|
|
2021
Q4 | $1.02M | Sell |
100,451
-21,996
| -18% | -$280K | ﹤0.01% | 3242 |
|
|
2021
Q3 | $1.64M | Buy |
122,447
+6,796
| +6% | +$111K | ﹤0.01% | 2948 |
|
|
2021
Q2 | $2.54M | Buy |
115,651
+42,288
| +58% | +$939K | ﹤0.01% | 2829 |
|
|
2021
Q1 | $1.76M | Sell |
73,363
-16,336
| -18% | -$380K | ﹤0.01% | 2904 |
|
|
2020
Q4 | $1.61M | Buy |
89,699
+17,694
| +25% | +$264K | ﹤0.01% | 2886 |
|
|
2020
Q3 | $832K | Sell |
72,005
-6,952
| -9% | -$115K | ﹤0.01% | 3048 |
|
|
2020
Q2 | $1.92M | Sell |
78,957
-9,564
| -11% | -$158K | ﹤0.01% | 2625 |
|
|
2020
Q1 | $976K | Buy |
88,521
+9,110
| +11% | +$170K | ﹤0.01% | 2835 |
|
|
2019
Q4 | $2.1M | Buy |
79,411
+11,312
| +17% | +$265K | ﹤0.01% | 2712 |
|
|
2019
Q3 | $1.55M | Sell |
68,099
-8,863
| -12% | -$279K | ﹤0.01% | 2818 |
|
|
2019
Q2 | $2.36M | Buy |
76,962
+15,562
| +25% | +$328K | ﹤0.01% | 2649 |
|
|
2019
Q1 | $1.02M | Buy |
61,400
+27,278
| +80% | +$517K | ﹤0.01% | 3034 |
|
|
2018
Q4 | $654K | Buy |
+34,122
| New | +$1.28M | ﹤0.01% | 3102 |
|
|
2018
Q2 | – | Sell |
-30,769
| Closed | -$1.14M | – | 3714 |
|
|
2018
Q1 | $1.14M | Buy |
+30,769
| New | +$821K | ﹤0.01% | 2922 |
|
Ameriprise's GTHX Position: Q3 2024 in Review
Ameriprise sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 34,900 shares — an estimated $79.6K sold.
Ameriprise first reported a position in GTHX in Q1 2018 and held it in 24 quarters. The position peaked at $2.54M in Q2 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Ameriprise reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Ameriprise sold 34,900 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $79.6K.
- Ameriprise first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 24 quarters.
- Ameriprise's G1 Therapeutics, Inc. Common Stock position peaked at $2.54M in Q2 2021.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.